首页> 外文期刊>International Journal of Medicinal Mushrooms >In vitro anti-Helicobacter pylori effects of medicinal mushroom extracts, with special emphasis on the Lion's mane mushroom, Hericium erinaceus (higher basidiomycetes).
【24h】

In vitro anti-Helicobacter pylori effects of medicinal mushroom extracts, with special emphasis on the Lion's mane mushroom, Hericium erinaceus (higher basidiomycetes).

机译:药用蘑菇提取物的体外抗幽门螺杆菌作用,特别着重于狮子的鬃毛蘑菇猴头菇(较高的担子菌)。

获取原文
获取原文并翻译 | 示例
           

摘要

Although the medicinal mushroom Hericium erinaceus is used extensively in traditional Chinese medicine to treat chronic superficial gastritis, the underlining pharmaceutical mechanism is yet to be fully understood. In this study, minimum inhibitory concentration (MIC) values of extracts prepared from the fruiting bodies of 14 mushroom species (H. erinaceus, Ganoderma lucidum, Cordyceps militaris, Pleurotus eryngii, P. ostreatus, Agrocybe aegerita, Lentinus edodes, Agaricus brasiliensis, A. bisporus, Coprinus comatus, Grifola frondosa, Phellinus igniarius, Flammulina velutipes, and Hypsizygus marmoreus) were determined against Helicobacter pylori using laboratory strains of ATCC 43504 and SS1 as well as 9 clinical isolates via an in vitro microplate agar diffusion assay. Ethanol extracts (EEs) of 12 mushrooms inhibited the growth of H. pylori in vitro, with MIC values <3 mg/mL. EEs of H. erinaceus and G. lucidum also inhibited Staphylococcus aureus (MIC 7360;10 mg/mL) but had no effect on the growth of two Escherichia coli test strains (MIC >10 mg/mL). MIC values of ethyl acetate fractions (EAFs) of H. erinaceus against 9 clinical isolates of H. pylori ranged between 62.5 and 250 micro g/mL. The bacteriostatic activity of EAFs was found to be concentration-dependant, and the half maximal inhibitory concentration and minimum bactericidal concentration values for H. pylori ATCC 43504 were 73.0 and 200 micro g/mL, respectively. The direct inhibitory effect of EEs and EAFs of H. erinaceus against H. pylori could be another pharmaceutical mechanism of medicinal mushrooms-besides the immunomodulating effect of polysaccharides, suggested previously-in the treatment of H. pylori-associated gastrointestinal disorders. Further research to identify the active component(s) is currently undertaking in our laboratory.Digital Object Identifier http://dx.doi.org/10.1615/IntJMedMushr.v15.i2.50
机译:尽管药用蘑菇猴头菇在中药中被广泛使用来治疗慢性浅表性胃炎,但其重要的药物作用机制尚待充分了解。在这项研究中,从14种蘑菇的子实体(H. erinaceus,Ganoderma lucidum,Cordyceps militaris,Pleurotus eryngii,P。ostreatus,Agrocybe aegerita,Lentinus edodes,巴西姬松茸,A。agriceris)的子实体制备的提取物的最低抑菌浓度(MIC)值。使用ATCC 43504和SS1的实验室菌株以及9种临床分离株通过体外微孔琼脂扩散测定法确定了双孢菌,鸡腿菇,灰树花,灰叶桑,金针菇和马氏Hypsizygus marmoreus)对幽门螺杆菌的抗性。 12种蘑菇的乙醇提取物(EEs)在体外抑制幽门螺杆菌的生长,MIC值<3 mg / mL。麻疯树和灵芝的EE也抑制金黄色葡萄球菌(MIC 7360; 10 mg / mL),但对两种大肠杆菌测试菌株(MIC> 10 mg / mL)的生长没有影响。相对于9例幽门螺杆菌临床分离株,大肠埃希氏菌的乙酸乙酯级分(EAFs)的MIC值在62.5至250 micro g / mL之间。发现EAF的抑菌活性是浓度依赖性的,并且幽门螺杆菌ATCC 43504的半数最大抑制浓度和最小杀菌浓度值分别为73.0和200μg/ mL。麻疯树的EEs和EAF对幽门螺杆菌的直接抑制作用可能是药用蘑菇的另一种药物机制,除了多糖的免疫调节作用外,以前曾提出过-在治疗幽门螺杆菌相关的胃肠道疾病中。当前正在实验室中进行进一步的研究以鉴定活性成分。数字对象标识符http://dx.doi.org/10.1615/IntJMedMushr.v15.i2.50

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号